Therapeutic applications of soft contact lenses in severe dry eye with chronic graft-versus-host disease
ISRCTN | ISRCTN05106737 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN05106737 |
Secondary identifying numbers | 001 |
- Submission date
- 30/11/2006
- Registration date
- 19/01/2007
- Last edited
- 14/01/2021
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Junko Ogawa
Scientific
Scientific
Shinanomachi 35 Shinjuku ku
Keio Univ Sch Med
Dept Ophthalmology
Tokyo
160-8582
Japan
junoga1102@yahoo.co.jp |
Study information
Study design | Retrospective, consisting of chart review of GVHD patients who received therapeutic contact lenses wear. Please note that chart reviews started in September 1, 2006 and will be finalised by spring next year. |
---|---|
Primary study design | Observational |
Secondary study design | Single-centre |
Study setting(s) | Hospital |
Study type | Screening |
Scientific title | Therapeutic applications of soft contact lenses in severe dry eye with chronic graft-versus-host disease |
Study objectives | Bandage contact lenses have favourable effects on the occular surface disease status in severe dry eye patients with chronic Graft-Versus-Host Disease (cGVHD). |
Ethics approval(s) | US Food and Drug Administration (FDA) approved contact lens material used for the study. Therapeutic contact lenses are not regarded as medical devices in Japan. According to our regulations, when contact lenses are deemed essential for therapeutic purposes by an ophthalmologist, permission from the university or hospital is not required. |
Health condition(s) or problem(s) studied | Chronic graft versus host disease |
Intervention | Silicone hydrogel Contact Lens use. Patients wore contact lenses continuously and replaced their contact lenses for every week to once in four weeks. Only patients with more than six months of follow up were included. |
Intervention type | Other |
Primary outcome measure | Pain relief |
Secondary outcome measures | Vital staining score |
Overall study start date | 01/09/2006 |
Completion date | 30/04/2007 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 10 patients |
Total final enrolment | 7 |
Key inclusion criteria | 1. Severe cGVHD dry eye subjects with fibrotic lid changes and trichiasis refractory to treatment with non-preserved artificial tears 2. Autologous serum eye drops 3. Bilateral punctal occlusion |
Key exclusion criteria | 1. Mild cGVHD patients 2. cGVHD |
Date of first enrolment | 01/09/2006 |
Date of final enrolment | 30/04/2007 |
Locations
Countries of recruitment
- Japan
Study participating centre
Shinanomachi 35 Shinjuku ku
Tokyo
160-8582
Japan
160-8582
Japan
Sponsor information
Ciba Vision (Japan)
Industry
Industry
Tennoz Central Tower 13
2-2-24 Higashi Shinagawa
Tokyo
140-0002
Japan
junoga1102@yahoo.co.jp | |
Website | http://www.cibavision.jp |
https://ror.org/01k1ftz35 |
Funders
Funder type
Other
Contact lenses were donated by CIBA vision. Costs incurred by vital staining, and
No information available
slit lamp examinations were covered by social insurance.
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Abstract results | results presented at ARVO | 01/05/2007 | 14/01/2021 | No | No |
Editorial Notes
14/01/2021: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.